The Effect of Dapagliflozin on Patients With Cardiomyopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Effect of Dapagliflozin on Patients With Cardiomyopathy — Stella

Recruiting

Back to Acute Decompensated Heart Failure (ADHF) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Egypt

Cairo University, Cairo

Key details

Phase

Post-approval study

Sponsor

May Mohamed Abdalla

Collaborators

Cairo University

Enrollment target

~100 participants

Started

August 2025

Primary completion

May 2026

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov